Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Metabolic dysregulation and emerging therapeutical targets for hepatocellular carcinoma
Danyu Du, Chan Liu, Mengyao Qin, et al.
Acta Pharmaceutica Sinica B (2021) Vol. 12, Iss. 2, pp. 558-580
Open Access | Times Cited: 365

Showing 1-25 of 365 citing articles:

Lactylation-Related Gene Signature Effectively Predicts Prognosis and Treatment Responsiveness in Hepatocellular Carcinoma
Zhe Cheng, Huichao Huang, Maoyu Li, et al.
Pharmaceuticals (2023) Vol. 16, Iss. 5, pp. 644-644
Open Access | Times Cited: 57
Non-alcoholic Fatty Liver Disease (NAFLD), Type 2 Diabetes, and Non-viral Hepatocarcinoma: Pathophysiological Mechanisms and New Therapeutic Strategies
Erica Vetrano, Luca Rinaldi, Andrea Mormone, et al.
Biomedicines (2023) Vol. 11, Iss. 2, pp. 468-468
Open Access | Times Cited: 47
Cancer metabolites: promising biomarkers for cancer liquid biopsy
Wenxiang Wang, Zhiwei Rong, Guangxi Wang, et al.
Biomarker Research (2023) Vol. 11, Iss. 1
Open Access | Times Cited: 45
Liquid biopsy techniques and lung cancer: diagnosis, monitoring and evaluation
Fei Ren, Qian Fei, Kun Qiu, et al.
Journal of Experimental & Clinical Cancer Research (2024) Vol. 43, Iss. 1
Open Access | Times Cited: 36
TRIM56 protects against nonalcoholic fatty liver disease by promoting the degradation of fatty acid synthase
Suowen Xu, Xiumei Wu, Sichen Wang, et al.
Journal of Clinical Investigation (2024) Vol. 134, Iss. 5
Open Access | Times Cited: 21
Role of Selenoprotein W in participating in the progression of non-alcoholic fatty liver disease
Zhiruo Miao, Wei Wang, Zhiying Miao, et al.
Redox Biology (2024) Vol. 71, pp. 103114-103114
Open Access | Times Cited: 21
The PI3K/Akt Pathway and Glucose Metabolism: A Dangerous Liaison in Cancer
Fabrizio Fontana, Gaia Giannitti, Sara Marchesi, et al.
International Journal of Biological Sciences (2024) Vol. 20, Iss. 8, pp. 3113-3125
Open Access | Times Cited: 21
Immunosuppressive tumor microenvironment in the progression, metastasis, and therapy of hepatocellular carcinoma: from bench to bedside
Yue Yin, Weibo Feng, Jie Chen, et al.
Experimental Hematology and Oncology (2024) Vol. 13, Iss. 1
Open Access | Times Cited: 19
The Asian Pacific association for the study of the liver clinical practice guidelines for the diagnosis and management of metabolic dysfunction-associated fatty liver disease
Mohammed Eslam, Jian‐Gao Fan, Ming‐Lung Yu, et al.
Hepatology International (2025)
Closed Access | Times Cited: 4
Exosomal cargos-mediated metabolic reprogramming in tumor microenvironment
Shiming Tan, Yiqing Yang, Wenjuan Yang, et al.
Journal of Experimental & Clinical Cancer Research (2023) Vol. 42, Iss. 1
Open Access | Times Cited: 40
Epidemiologic, Genetic, Pathogenic, Metabolic, Epigenetic Aspects Involved in NASH-HCC: Current Therapeutic Strategies
Jorge Gutiérrez‐Cuevas, Silvia Lucano‐Landeros, Daniel López-Cifuentes, et al.
Cancers (2022) Vol. 15, Iss. 1, pp. 23-23
Open Access | Times Cited: 39
circROBO1 promotes prostate cancer growth and enzalutamide resistance via accelerating glycolysis
Zhigang Zhou, Jing Qin, Cailu Song, et al.
Journal of Cancer (2023) Vol. 14, Iss. 13, pp. 2574-2584
Open Access | Times Cited: 39
Regulation of Autophagy via Carbohydrate and Lipid Metabolism in Cancer
Javad Alizadeh, Mahboubeh Kavoosi, Navjit Singh, et al.
Cancers (2023) Vol. 15, Iss. 8, pp. 2195-2195
Open Access | Times Cited: 37
A RIPK3-independent role of MLKL in suppressing parthanatos promotes immune evasion in hepatocellular carcinoma
Xi‐Fei Jiang, Wenjia Deng, Siyao Tao, et al.
Cell Discovery (2023) Vol. 9, Iss. 1
Open Access | Times Cited: 34
WNT/β-catenin signaling in hepatocellular carcinoma: The aberrant activation, pathogenic roles, and therapeutic opportunities
Anna Gajos-Michniewicz, Małgorzata Czyż
Genes & Diseases (2023) Vol. 11, Iss. 2, pp. 727-746
Open Access | Times Cited: 32
Metabolic Reprogramming of HCC: A New Microenvironment for Immune Responses
Beatrice Foglia, Marc Beltrà, Salvatore Sutti, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 8, pp. 7463-7463
Open Access | Times Cited: 31
Obesity, non-alcoholic fatty liver disease and hepatocellular carcinoma: current status and therapeutic targets
Yinshuang Chen, Weipeng Wang, Maria P. Morgan, et al.
Frontiers in Endocrinology (2023) Vol. 14
Open Access | Times Cited: 30
Xie Zhuo Tiao Zhi formula modulates intestinal microbiota and liver purine metabolism to suppress hepatic steatosis and pyroptosis in NAFLD therapy
Jiannan Qiu, Lin Chen, Ling Zhang, et al.
Phytomedicine (2023) Vol. 121, pp. 155111-155111
Open Access | Times Cited: 30
Autophagy activation is required for N6-methyladenosine modification to regulate ferroptosis in hepatocellular carcinoma
Yujia Li, Mei Guo, Yangling Qiu, et al.
Redox Biology (2023) Vol. 69, pp. 102971-102971
Open Access | Times Cited: 28
Nuclear Receptor PPARα as a Therapeutic Target in Diseases Associated with Lipid Metabolism Disorders
Ping Hu, Kaiqi Li, Xiaoxu Peng, et al.
Nutrients (2023) Vol. 15, Iss. 22, pp. 4772-4772
Open Access | Times Cited: 27
Identification of potential feature genes in non-alcoholic fatty liver disease using bioinformatics analysis and machine learning strategies
Zhaohui Zhang, Shihao Wang, Zhengwen Zhu, et al.
Computers in Biology and Medicine (2023) Vol. 157, pp. 106724-106724
Open Access | Times Cited: 26
Combination treatment with FAAH inhibitors/URB597 and ferroptosis inducers significantly decreases the growth and metastasis of renal cell carcinoma cells via the PI3K-AKT signaling pathway
Junfeng Hao, Qiguang Chen, Yongmin Feng, et al.
Cell Death and Disease (2023) Vol. 14, Iss. 4
Open Access | Times Cited: 24
Piezoeletric cold atmospheric plasma induces apoptosis and autophagy in human hepatocellular carcinoma cells through blocking glycolysis and AKT/mTOR/HIF-1α pathway
Yanhong Wang, Xinyu Mang, Danni Li, et al.
Free Radical Biology and Medicine (2023) Vol. 208, pp. 134-152
Open Access | Times Cited: 23
Metabolic reprogramming and immune evasion: the interplay in the tumor microenvironment
Haixia Zhang, Shizhen Li, Dan Wang, et al.
Biomarker Research (2024) Vol. 12, Iss. 1
Open Access | Times Cited: 15
Exploring the mystery of tumor metabolism: Warburg effect and mitochondrial metabolism fighting side by side
Yongxin Yu, Yulang Jiang, Christian Glandorff, et al.
Cellular Signalling (2024) Vol. 120, pp. 111239-111239
Closed Access | Times Cited: 13
Page 1 - Next Page

Scroll to top